NCT07817264

Brief Summary

A randomized controlled experimental study has been conducted to determine the effects of Enhanced Recovery After Surgery (ERAS) protocols on patient outcomes in the Cardiovascular Surgery Clinic.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 30, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2025

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

September 8, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 14, 2026

Completed
Last Updated

September 14, 2026

Status Verified

October 1, 2024

Enrollment Period

Same day

First QC Date

September 8, 2026

Last Update Submit

September 8, 2026

Conditions

Keywords

ERASPostoperative PainCardiac SurgeryAnxietySymptoms

Outcome Measures

Primary Outcomes (1)

  • Quality of Recovery-40 (QoR-40) Score

    The scale is a 5-point Likert-type scale, and the total score ranges from 40 to 200 based on the sum of all items. A higher total score indicates that the patients' emotional and physical well-being is at the expected and favorable level following surgery, whereas a lower score indicates that their well-being has been adversely affected. With a Cronbach's alpha value of 0.936, the questionnaire is a valid and reliable instrument for assessing recovery following

    one month

Secondary Outcomes (1)

  • Cardiac Surgery-Related Symptom Score

    one month

Other Outcomes (2)

  • State-Trait Anxiety Inventory Score

    1 month

  • Postoperative Delirium

    One month

Study Arms (2)

ENHANCED RECOVERY AFTER SURGERY (ERAS) GROUP

EXPERIMENTAL

Patients in the ERAS group received a multimodal enhanced recovery program covering the preoperative, intraoperative, and postoperative periods. Interventions included patient education and counseling, nutritional assessment and support when indicated, preoperative oral carbohydrate loading, appropriate fasting, and avoidance of mechanical bowel preparation. Intraoperative interventions included multimodal anesthesia, lung-protective ventilation, maintenance of normothermia, antimicrobial prophylaxis, blood conservation, and minimization of surgical drains. Postoperative care included early extubation, respiratory physiotherapy, incentive spirometry, coughing and leg exercises, early mobilization and oral intake, multimodal analgesia, thromboprophylaxis, glycemic control, wound care, delirium screening, and early removal of chest tubes and urinary catheters when clinically appropriate. Quality of recovery, anxiety, pain, and cardiovascular surgery-related symptoms were assessed during

Behavioral: Enhanced Recovery After Surgery (ERAS) Protocol

CONTROL GROUP

NO INTERVENTION

Patients in the control group received routine perioperative care according to standard clinical practice. No specific Enhanced Recovery After Surgery (ERAS) protocol was applied. Patients received standard preoperative, intraoperative, and postoperative care, including routine monitoring, pain management, respiratory care, mobilization, nutritional management, and other clinical interventions as indicated by the treating healthcare team. Patient outcomes were assessed at the same time points as in the ERAS group.

Interventions

A comprehensive 31-factor Enhanced Recovery After Surgery (ERAS) program was implemented throughout the perioperative period in patients undergoing elective coronary artery bypass grafting (CABG) surgery. The program included patient education and counseling, nutritional assessment, preoperative oral carbohydrate loading, appropriate fasting, avoidance of mechanical bowel preparation, multimodal anesthesia and analgesia, lung-protective ventilation, normothermia, antimicrobial prophylaxis, blood conservation, prevention of postoperative nausea and vomiting, early extubation, respiratory physiotherapy, incentive spirometry, coughing and leg exercises, early mobilization and oral intake, thromboprophylaxis, glycemic control, systematic delirium screening, wound care, and early removal of chest tubes and urinary catheters when clinically appropriate. Quality of recovery, anxiety, pain, and cardiovascular surgery-related symptoms were assessed at predefined postoperative time points.

ENHANCED RECOVERY AFTER SURGERY (ERAS) GROUP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being admitted for their first planned coronary artery bypass graft (CABG) surgery;
  • Undergoing off-pump coronary artery bypass (OPCAB) surgery without the use of a cardiopulmonary bypass machine;
  • Not undergoing any additional surgical procedure during CABG surgery;
  • Having no abnormalities in preoperative laboratory parameters, including hemoglobin, albumin, and electrolytes;
  • Having no cognitive impairment;
  • Having no psychological or mental disorder;
  • Being able to speak Turkish and communicate effectively;
  • Being at least literate;
  • Being 18 years of age or older;
  • Being reachable by telephone during the follow-up period; and
  • Providing informed consent to participate in the study.

You may not qualify if:

  • Having previously undergone CABG surgery;
  • Undergoing CABG surgery using cardiopulmonary bypass with the heart arrested;
  • Undergoing any additional surgical procedure during CABG surgery;
  • Having electrolyte abnormalities in preoperative laboratory parameters;
  • Having cognitive impairment;
  • Having a psychological or mental disorder;
  • Being unable to speak Turkish, communicate effectively, or provide consent to participate in the study;
  • Being unable to read and write;
  • Being younger than 18 years of age;
  • Being unreachable by telephone during the follow-up period;
  • Withdrawing from the study after initially agreeing to participate;
  • Undergoing any surgical operation after hospital admission; or
  • Dying during the study intervention or follow-up period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bolu Abant İzzet Baysal University İzzet Baysal Training and Research Hospital

Bolu, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, PostoperativeAnxiety Disorders

Interventions

Enhanced Recovery After SurgeryClinical Protocols

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

Perioperative CareSurgical Procedures, OperativeTherapeuticsEpidemiologic Study CharacteristicsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and Evaluation

Study Officials

  • Aynur Ülkü

    Karabuk Universty

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: After confirming that the individuals met the inclusion and exclusion criteria, eligible participants were randomly assigned to either the Enhanced Recovery After Surgery (ERAS) group or the control group using a one-to-one allocation ratio. Each participant had an equal probability of being assigned to either group, and the allocation was independent of previous assignments. The sealed envelope method was used to determine whether participants would be assigned to the ERAS or control group. The ERAS group was coded as "0" and the control group as "1". When an eligible participant was identified, a person who was not involved in the study was presented with a set of mixed, sealed envelopes and asked to randomly select one envelope. The selected envelope was then opened to determine the group to which the participant would be assigned. This procedure was used to minimize selection bias by ensuring that group allocation was performed randomly and independently of the researcher.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 8, 2026

First Posted

September 14, 2026

Study Start

October 30, 2024

Primary Completion

October 30, 2024

Study Completion

May 30, 2025

Last Updated

September 14, 2026

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Individual participant-level data will not be shared publicly due to patient privacy and confidentiality requirements. However, the aggregated results of the study will be reported and made available through scientific publication. No personally identifiable patient information will be included in the published results.

Locations